NCT06401876Completed
Extracellular Vesicle Cargo in Obesity and Type 2 Diabetes
Profiling Extracellular Vesicle Cargo in Obesity and Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 20 Aug 2025
Brief summary (registry, in English)
The purpose of this research is to obtain blood samples before and after a bariatric procedure to better understand the reasons for glucose intolerance and insulin resistance (diabetes) in the obesity, and the reasons for improvement of diabetes after bariatric surgery
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 24 (actual)
- First submitted
- 2 May 2024
- Start date
- 1 May 2024
- Primary completion date
- 31 Jul 2025
- Lead sponsor
- Mayo Clinic
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT06401876
What you commit to
- Study type: Observational
- Participants enrolled: 24
- From 1 May 2024 to the primary completion date, 31 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Disqualified for Bariatric Surgery.
Other
- BMI \< 35 kg/m\^2.
Who the study is looking for
- Enrolled in the Bariatric Surgery Program.
- Patients with A1c of 6.5 or higher within the last 6 months. OR
- Patients with A1c less than 6.5; have diagnosis of stable type 2 diabetes for \> 6 months.
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Florida Coordinator of this site? Confirm its status | Jacksonville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.